ZTS logo

Zoetis Inc. (ZTS)

Profile

Full Name

Zoetis Inc.

Ticker

NYSE: ZTS

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

February 1, 2013

Indexes

S&P 500

Website

http://www.zoetis.com

Employees

13800

Key Details

Price

$154.96(-2.42%)

Market cap

Last Dividend

$0.50

TTM Dividend yield

1.20%

Annual revenue

$9.26B(+8.33% YoY)

Annual EPS

$5.47(+7.89% YoY)

PE ratio

27.82

Next earnings date

Aug 5, 2025

Next ex-dividend date

Jul 18, 2025

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $154.96
    ZTS price is $154.96

    30-Day Relative Volume

    0.77
    ZTS 30-day relative volume is 0.77

    Price Performance

    Price Most recent change

    -2.42%
    ZTS price was down -2.42% on Jul 11, 2025

    Price YTD change

    -4.89%
    ZTS price is down -4.89% since January 1st

    Price 1-year change

    -12.82%
    ZTS price is down -12.82% year-on-year

    Price 3-year change

    -12.47%
    ZTS price is down -12.47% over the past 3 years

    Price Range

    Price All-time high

    $249.27
    ZTS price is currently -37.83% below its historical high of $249.27

    Price 3-year low

    $124.15
    ZTS price is currently +24.82% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $68.99B
    ZTS market capitalization is $68.99 billion

    Market cap 3-year change

    -16.84%
    ZTS market capitalization is down -16.84% over the past 3 years

    Market cap All-time high

    $116.88B
    ZTS market capitalization is currently -40.97% below its historical high of $116.88 billion

    Market cap sector rank

    97.77%
    ZTS market capitalization is higher than 97.77% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -1.9%
    ZTS shares outstanding is down -1.9% year-on-year

    Shares Outstanding 3-Year Change

    -4.99%
    ZTS shares outstanding is down -4.99% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.53
    ZTS beta is 0.53

    200-day SMA

    $168.41
    ZTS price is currently -7.99% below its 200-day simple moving average

    50-day SMA

    $161.14
    ZTS price is currently -3.84% below its 50-day simple moving average

    RSI

    39.26
    ZTS 14-day relative strength index is 39.26

    Volume

    0.77
    ZTS 30-day relative volume is 0.77

    ATR

    $3.29
    ZTS average true range is $3.29

    10-day Historical Volatility

    18.69%
    ZTS 10-day historical volatility is 18.69%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.50
    ZTS last dividend was $0.50 per share, with an ex-dividend date of April 21, 2025

    Next Dividend

    $0.50
    ZTS has announced a dividend of $0.50 per share, with an ex-dividend date set for July 18, 2025

    Dividend per share

    Dividend per share

    $1.73
    ZTS annual dividend per share is $1.73

    Dividend per share Sector Rank

    62.35%
    ZTS annual dividend per share is higher than 62.35% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +15.2%
    ZTS annual dividend per share is up +15.2% year-on-year

    Dividend per share 3-Year Change

    +72.8%
    ZTS annual dividend per share is up +72.8% over the past 3 years

    Dividend yield

    Dividend yield

    1.12%
    ZTS annual dividend yield is 1.12%

    Dividend yield Sector Rank

    32.14%
    ZTS annual dividend yield is higher than 32.14% of companies in Healthcare sector

    Other

    Payout ratio

    31.62%
    ZTS annual payout ratio is 31.62%

    Dividends paid

    $786.00M
    ZTS annual dividends paid is $786.00 million

    Free cash flow

    $2.30B
    ZTS annual free cash flow is $2.30 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $9.26B
    ZTS annual revenue is $9.26 billion

    Revenue Analysts estimate

    $9.48B
    ZTS annual revenue is currently -2.38% lower than the consensus analysts' forecast

    Revenue 1-year change

    +8.33%
    ZTS annual revenue is up +8.33% year-on-year

    Revenue Sector rank

    93.7%
    ZTS annual revenue is higher than 93.7% of companies in Healthcare sector

    EPS

    EPS

    $5.47
    ZTS annual earnings per share is $5.47

    EPS Analysts estimate

    $6.23
    ZTS annual earnings per share is currently -12.15% lower than the consensus analysts' forecast

    EPS 1-year change

    +7.89%
    ZTS annual earnings per share is up +7.89% year-on-year

    EPS Sector rank

    95.76%
    ZTS annual earnings per share is higher than 95.76% of companies in Healthcare sector

    Profit

    Gross profit

    $6.54B
    ZTS annual gross profit is $6.54 billion

    Gross margin

    70.62%
    ZTS annual gross profit margin is 70.62%

    Operating profit

    $3.39B
    ZTS annual operating income is $3.39 billion

    Operating margin

    36.65%
    ZTS annual operating profit margin is 36.65%

    Net income

    $2.49B
    ZTS annual net profit is $2.49 billion

    Net margin

    26.86%
    ZTS annual net profit margin is 26.86%

    Expenses

    Total expenses

    $5.86B
    ZTS annual total expenses is $5.86 billion

    Operating expenses

    $3.15B
    ZTS annual total operating expenses is $3.15 billion

    Cost of goods sold

    $2.72B
    ZTS annual cost of goods sold is $2.72 billion

    Selling, general & administrative expenses

    $2.32B
    ZTS annual SGA is $2.32 billion

    Depreciation and amortization

    $497.00M
    ZTS annual depreciation & amortization is $497.00 million

    Interest expense

    $225.00M
    ZTS annual interest expense is $225.00 million

    Income tax

    $637.00M
    ZTS annual income tax is $637.00 million

    EBIT & EBITDA

    EBIT

    $3.36B
    ZTS annual earnings before interest & taxes is $3.36 billion

    EBITDA

    $3.85B
    ZTS annual EBITDA is $3.85 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $14.24B
    ZTS annual total assets is $14.24 billion

    Non current assets

    $8.25B
    ZTS annual long term assets is $8.25 billion

    Current assets

    $5.99B
    ZTS annual total current assets is $5.99 billion

    Cash and cash equivalents

    $1.99B
    ZTS annual cash & cash equivalents is $1.99 billion

    Accounts receivable

    $1.32B
    ZTS annual accounts receivable is $1.32 billion

    Inventory

    $2.31B
    ZTS annual inventory is $2.31 billion

    Liabilities

    Total liabilities

    $9.47B
    ZTS annual total liabilities is $9.47 billion

    Long term liabilities

    $6.05B
    ZTS annual total long term liabilities is $6.05 billion

    Current liabilities

    $3.41B
    ZTS annual total current liabilities is $3.41 billion

    Accounts payable

    $433.00M
    ZTS annual accounts payable is $433.00 million

    Debt

    Total debt

    $6.74B
    ZTS annual total debt is $6.74 billion

    Total debt 1-year change

    -0.16%
    ZTS annual total debt is down -0.16% year-on-year

    Long term debt

    $5.39B
    ZTS annual long term debt is $5.39 billion

    Short term debt

    $1.35B
    ZTS annual short term debt is $1.35 billion

    Equity & Capital

    Shareholders equity

    $4.77B
    ZTS annual stockholders equity is $4.77 billion

    Book value

    $4.77B
    ZTS annual book value is $4.77 billion

    Retained earnings

    $11.97B
    ZTS annual retained earnings is $11.97 billion

    Working capital

    $2.57B
    ZTS annual working capital is $2.57 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $2.95B
    ZTS annual cash flow from operations is $2.95 billion

    Cash from operations 1-year change

    +25.5%
    ZTS annual cash flow from operations is up +25.5% year-on-year

    Cash from investing

    -$315.00M
    ZTS annual cash flow from investing activities is -$315.00 million

    Cash from investing 1-year change

    +59.46%
    ZTS annual cash flow from investing activities is up +59.46% year-on-year

    Cash from financing

    -$2.66B
    ZTS annual cash flow from financing activities is -$2.66 billion

    Cash from financing 1-year change

    +14.44%
    ZTS annual cash flow from financing activities is up +14.44% year-on-year

    CAPEX

    CAPEX

    $655.00M
    ZTS annual capital expenditures is $655.00 million

    CAPEX 1-year change

    -10.52%
    ZTS annual capital expenditures is down -10.52% year-on-year

    Free Cash Flow

    Free cash flow

    $2.30B
    ZTS annual free cash flow is $2.30 billion

    Free cash flow 1-year change

    +41.76%
    ZTS annual free cash flow is up +41.76% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    70.62%
    ZTS annual gross profit margin is 70.62%

    Operating margin

    36.65%
    ZTS annual operating profit margin is 36.65%

    Net margin

    26.86%
    ZTS annual net profit margin is 26.86%

    ROA & ROE

    ROA

    17.43%
    ZTS annual return on assets is 17.43%

    ROE

    50.94%
    ZTS annual return on equity is 50.94%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    27.82
    ZTS price to earnings ratio is 27.82

    PE ratio Sector rank

    56.81%
    ZTS price to earnings ratio is higher than 56.81% of companies in Healthcare sector

    PB Ratio

    PB ratio

    14.82
    ZTS price to book ratio is 14.82

    PB ratio Sector rank

    93.13%
    ZTS price to book ratio is higher than 93.13% of companies in Healthcare sector

    PS Ratio

    PS ratio

    7.43
    ZTS price to sales ratio is 7.43

    PS ratio Sector rank

    72.65%
    ZTS price to sales ratio is higher than 72.65% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $74.02B
    ZTS enterprise value is $74.02 billion

    Enterprise value Sector rank

    97.75%
    ZTS enterprise value is higher than 97.75% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    18.95
    ZTS EV/EBITDA is 18.95

    EV/EBITDA Sector rank

    91.03%
    ZTS EV/EBITDA is higher than 91.03% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.75
    ZTS annual current ratio is 1.75

    Quick ratio

    1.08
    ZTS annual quick ratio is 1.08

    Leverage

    Debt to equity

    1.38
    ZTS annual debt to equity ratio is 1.38

    Interest coverage ratio

    14.92
    ZTS annual interest coverage ratio is 14.92

    Risk & Stability

    Piotroski F-Score

    8
    ZTS piotroski f-score is 8

    Altman Z-Score

    7.19
    ZTS altman z-score is 7.19

    Analyst ratings

    Recent major analysts updates

    Jun 18, 25 Stifel
    Hold
    May 12, 25 Piper Sandler
    Overweight
    May 7, 25 UBS
    Neutral
    Apr 14, 25 Stifel
    Buy
    Feb 27, 25 Piper Sandler
    Overweight
    Feb 14, 25 Morgan Stanley
    Overweight
    Feb 14, 25 Barclays
    Overweight
    Feb 10, 25 Piper Sandler
    Overweight
    Jan 29, 25 Morgan Stanley
    Overweight
    Jan 7, 25 Stifel
    Buy

    Institutional Ownership

    Screeners with ZTS included

    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    Healthcare sector
    • What is the ticker symbol for Zoetis Inc.?
    • Does Zoetis Inc. pay dividends?
    • What sector is Zoetis Inc. in?
    • What industry is Zoetis Inc. in?
    • What country is Zoetis Inc. based in?
    • When did Zoetis Inc. go public?
    • Is Zoetis Inc. in the S&P 500?
    • Is Zoetis Inc. in the NASDAQ 100?
    • Is Zoetis Inc. in the Dow Jones?
    • When was Zoetis Inc.'s last earnings report?
    • When does Zoetis Inc. report earnings?

    What is the ticker symbol for Zoetis Inc.?

    The ticker symbol for Zoetis Inc. is NYSE:ZTS

    Does Zoetis Inc. pay dividends?

    Yes, Zoetis Inc. pays dividends. The last payment was $0.50, with an ex-dividend date on April 21, 2025

    What sector is Zoetis Inc. in?

    Zoetis Inc. is in the Healthcare sector

    What industry is Zoetis Inc. in?

    Zoetis Inc. is in the Drug Manufacturers - Specialty & Generic industry

    What country is Zoetis Inc. based in?

    Zoetis Inc. is headquartered in United States

    When did Zoetis Inc. go public?

    Zoetis Inc.'s initial public offering (IPO) was on February 1, 2013

    Is Zoetis Inc. in the S&P 500?

    Yes, Zoetis Inc. is included in the S&P 500 index

    Is Zoetis Inc. in the NASDAQ 100?

    No, Zoetis Inc. is not included in the NASDAQ 100 index

    Is Zoetis Inc. in the Dow Jones?

    No, Zoetis Inc. is not included in the Dow Jones index

    When was Zoetis Inc.'s last earnings report?

    Zoetis Inc.'s most recent earnings report was on May 6, 2025

    When does Zoetis Inc. report earnings?

    The next expected earnings date for Zoetis Inc. is August 5, 2025
    On this page